Aytu biopharma announces pricing of $7.6 million registered offering

Englewood, co / accesswire / march 2, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the placement to a healthcare-dedicated institutional investor in an underwritten offering of 3,030,000 shares of its common stock, pre-funded warrants to purchase up to 3,030,000 shares of its common stock, and common warrants to purchase up to 6,666,000 shares of its common stock (the "offering"). the shares of common stock and the pre-funded warrants are each being sold in combination with corresponding common warrants, with one common warrant to purchase 1.1 shares of common stock for each share of common stock or each pre-funded warrant sold.
AYTU Ratings Summary
AYTU Quant Ranking